Your browser doesn't support javascript.
Early detection of COVID-19 outbreaks using human mobility data.
Guan, Grace; Dery, Yotam; Yechezkel, Matan; Ben-Gal, Irad; Yamin, Dan; Brandeau, Margaret L.
  • Guan G; Department of Management Science and Engineering, Stanford University, Stanford, California, United States of America.
  • Dery Y; Department of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel.
  • Yechezkel M; Department of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel.
  • Ben-Gal I; Department of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel.
  • Yamin D; Department of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel.
  • Brandeau ML; Department of Management Science and Engineering, Stanford University, Stanford, California, United States of America.
PLoS One ; 16(7): e0253865, 2021.
Article in English | MEDLINE | ID: covidwho-1318314
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

Contact mixing plays a key role in the spread of COVID-19. Thus, mobility restrictions of varying degrees up to and including nationwide lockdowns have been implemented in over 200 countries. To appropriately target the timing, location, and severity of measures intended to encourage social distancing at a country level, it is essential to predict when and where outbreaks will occur, and how widespread they will be.

METHODS:

We analyze aggregated, anonymized health data and cell phone mobility data from Israel. We develop predictive models for daily new cases and the test positivity rate over the next 7 days for different geographic regions in Israel. We evaluate model goodness of fit using root mean squared error (RMSE). We use these predictions in a five-tier categorization scheme to predict the severity of COVID-19 in each region over the next week. We measure magnitude accuracy (MA), the extent to which the correct severity tier is predicted.

RESULTS:

Models using mobility data outperformed models that did not use mobility data, reducing RMSE by 17.3% when predicting new cases and by 10.2% when predicting the test positivity rate. The best set of predictors for new cases consisted of 1-day lag of past 7-day average new cases, along with a measure of internal movement within a region. The best set of predictors for the test positivity rate consisted of 3-days lag of past 7-day average test positivity rate, along with the same measure of internal movement. Using these predictors, RMSE was 4.812 cases per 100,000 people when predicting new cases and 0.79% when predicting the test positivity rate. MA in predicting new cases was 0.775, and accuracy of prediction to within one tier was 1.0. MA in predicting the test positivity rate was 0.820, and accuracy to within one tier was 0.998.

CONCLUSIONS:

Using anonymized, macro-level data human mobility data along with health data aids predictions of when and where COVID-19 outbreaks are likely to occur. Our method provides a useful tool for government decision makers, particularly in the post-vaccination era, when focused interventions are needed to contain COVID-19 outbreaks while mitigating the collateral damage from more global restrictions.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Disease Control / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0253865

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Disease Control / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0253865